National Cancer Institute
at the National Institutes of Health
- Endometrial Cancer Prevention (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about factors that may influence the risk of developing endometrial cancer and about research aimed at the prevention of this disease.
- Clinical Trials to Prevent Endometrial Cancer
Check for endometrial cancer prevention trials from NCI's PDQ® Cancer Clinical Trials Registry now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features.
- Understanding Gene Testing
Illustrates what genes are, explains how mutations occur and are identified within genes, and discusses the benefits and limitations of gene testing for cancer and other disorders.
- Cancer Genetics Services Directory
Directory of professionals who provide services related to cancer genetic risk assessment, counseling, and testing.
- Cancer Genetics Overview (PDQ®)
[ health professional ]
Expert-reviewed information summary in which the features of hereditary cancer and the structure and content of other PDQ cancer genetics summaries are described. The summary also contains an extensive list of genetics resources available online.
Causes and Risk Factors
- Oral Contraceptives and Cancer Risk
A fact sheet about research on the association of oral contraceptive use with risk of various cancers.
- The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers
STAR is a clinical trial designed to see how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in postmenopausal women who are at an increased risk of developing the disease.
- Postmenopausal Hormone Therapy
Information from the National Heart, Lung, and Blood Institute's Web site. Menopausal hormone use usually involves treatment with either estrogen alone or estrogen in combination with progesterone or progestin.